Regal Partners Ltd Has $17.71 Million Stock Holdings in Opthea Limited Unsponsored ADR (NASDAQ:OPT)

Key Points

• Regal Partners Ltd increased its stake in Opthea Limited Unsponsored ADR by 78.6% in the first quarter, totaling 5,193,688 shares worth approximately $17.71 million.
• Institutional investors and hedge funds own around 55.95% of Opthea's stock, highlighting significant interest from the investment community.
• Opthea's shares recently opened at $3.41 and have a 52-week trading range between $1.79 and $6.30.

Regal Partners Ltd boosted its position in shares of Opthea Limited Unsponsored ADR (NASDAQ:OPT - Free Report) by 78.6% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 5,193,688 shares of the company's stock after purchasing an additional 2,286,285 shares during the quarter. Opthea comprises 1.8% of Regal Partners Ltd's holdings, making the stock its 16th biggest position. Regal Partners Ltd owned 3.37% of Opthea worth $17,710,000 at the end of the most recent quarter.

Separately, Citadel Advisors LLC bought a new stake in shares of Opthea in the 4th quarter valued at about $79,000. Institutional investors and hedge funds own 55.95% of the company's stock.

Opthea Price Performance

Shares of OPT stock remained flat at $3.41 on Friday. The business has a 50-day moving average of $3.41 and a 200 day moving average of $3.69. Opthea Limited Unsponsored ADR has a 1 year low of $1.79 and a 1 year high of $6.30.

Opthea Company Profile

Opthea Limited, a clinical stage biopharmaceutical company, engages in the development and commercialization of therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage.